D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YHNA
2301
YHN Acquisition I Ltd
YHNA
$46.8M
| $3.06M | ﹤0.01% |
296,749
| – | – |
|
2302
Artisan Partners
APAM
$2.86B
| $3.06M | ﹤0.01% |
69,030
+47,355
| +218% | +$1.89M |
|
2303
CALL
UGI
UGI
$7.87B
| $3.06M | ﹤0.01% |
+83,900
| New | +$2.89M |
|
2304
First Busey Corp
BUSE
$2.6B
| $3.05M | ﹤0.01% |
133,229
-149,282
| -53% | -$3.23M |
|
|
GSHR
2305
Gesher Acquisition Corp II
GSHR
$215M
| $3.04M | ﹤0.01% |
+300,000
| New | +$3.01M |
|
|
PPBI
2306
DELISTED
Pacific Premier Bancorp
PPBI
| $3.04M | ﹤0.01% |
144,158
-39,525
| -22% | -$822K |
|
|
ALEX
2307
DELISTED
Alexander & Baldwin
ALEX
| $3.03M | ﹤0.01% |
170,122
-68,892
| -29% | -$1.2M |
|
2308
CALL
Ovintiv
OVV
$17B
| $3.03M | ﹤0.01% |
79,700
-7,200
| -8% | -$264K |
|
2309
Castle Biosciences
CSTL
$742M
| $3.03M | ﹤0.01% |
148,190
-40,987
| -22% | -$759K |
|
|
ORLA
2310
PUT
Orla Mining
ORLA
$3.36B
| $3.02M | ﹤0.01% |
+300,000
| New | +$3.12M |
|
2311
Navitas Semiconductor
NVTS
$2.54B
| $3.01M | ﹤0.01% |
460,102
+28,494
| +7% | +$110K |
|
2312
PUT
Lincoln National
LNC
$7.92B
| $3.01M | ﹤0.01% |
87,100
| – | – |
|
|
COLA
2313
Columbus Acquisition Corp
COLA
$48M
| $3.01M | ﹤0.01% |
+297,000
| New | +$2.99M |
|
|
AGNT
2314
AGNT Inc
AGNT
$629M
| $3M | ﹤0.01% |
329,473
+240,331
| +270% | +$2.1M |
|
2315
CALL
PepsiCo
PEP
$196B
| $3M | ﹤0.01% |
22,700
-134,400
| -86% | -$18.1M |
|
|
CADE
2316
DELISTED
Cadence Bank
CADE
| $2.99M | ﹤0.01% |
+93,634
| New | +$2.81M |
|
2317
PUT
Gilead Sciences
GILD
$165B
| $2.99M | ﹤0.01% |
27,000
-58,100
| -68% | -$6.18M |
|
|
SNDK
2318
CALL
Sandisk
SNDK
$150B
| $2.99M | ﹤0.01% |
65,868
-6,171
| -9% | -$236K |
|
|
AMWD
2319
DELISTED
American Woodmark
AMWD
| $2.99M | ﹤0.01% |
55,957
+8,274
| +17% | +$467K |
|
|
CMA
2320
PUT
DELISTED
Comerica
CMA
| $2.98M | ﹤0.01% |
50,000
| – | – |
|
2321
PUT
Phillips 66
PSX
$82.9B
| $2.98M | ﹤0.01% |
25,000
-51,100
| -67% | -$5.72M |
|
2322
GameStop
GME
$9.8B
| $2.97M | ﹤0.01% |
121,883
-458,252
| -79% | -$12.3M |
|
2323
CALL
GeneDx Holdings
WGS
$1.89B
| $2.97M | ﹤0.01% |
32,200
+26,200
| +437% | +$2.06M |
|
|
CIM
2324
Chimera Investment
CIM
$1.06B
| $2.97M | ﹤0.01% |
213,902
+111,510
| +109% | +$1.42M |
|
2325
CALL
GitLab
GTLB
$5.75B
| $2.96M | ﹤0.01% |
65,700
-100,700
| -61% | -$4.6M |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.